Expanding Product Portfolio InBio continuously innovates with new diagnostic technologies such as ELISA 2.0, MARIA for Foods, and human IgE monoclonal antibodies, creating opportunities for sales of advanced testing kits and reagents across allergy, food safety, and environmental testing sectors.

Strategic Partnerships Recent collaborations with GX Group and LGC Standards highlight InBio's active efforts to expand distribution channels and increase market reach, making these partnerships potential avenues for sales growth and product integration.

Market Expanding Focus InBio's development of COVID-19 tests using T cells and the launch of related products indicate a strategic move into infectious disease diagnostics, offering opportunities to sell alongside existing allergy and environmental testing solutions.

Innovation Driven With ongoing R&D investments and a broad scientific expertise base, InBio is positioned to develop novel solutions tailored to customer needs, opening up possibilities for customized product offerings and collaborative research projects.

Digital Outreach The launch of a new website and active online presence through platforms like Mailchimp and Intercom suggest a focus on digital marketing and customer engagement, presenting avenues for targeted campaigns and lead generation efforts.